Infosys (INFY) filed a counterclaim against Cognizant Technology Solutions (CTSH) in a US court, accusing the company and its Chief Executive Officer Ravi Kumar of anticompetitive tactics, media outlets reported Friday, citing the lawsuit.
Cognizant was alleged to have misused sensitive information to hinder the growth of Infosys' health-care platform and poached key executives, the counterclaim in a Texas federal court said, according to the reports.
Cognizant subsidiary TriZetto had accused Infosys of stealing trade secrets.
Infosys is seeking a jury trial and asking the court to invalidate Cognizant's nondisclosure agreements and award damages, the reports said.
Infosys and Cognizant didn't immediately respond to requests for comments from MT Newswires.
Infosys shares were little changed in recent Friday trading, and Cognizant fell 0.6%
Price: 22.79, Change: +0.01, Percent Change: +0.04
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。